Sermorelin Acetate
A 29-amino acid analogue of endogenous Growth Hormone-Releasing Hormone (GHRH). Sermorelin acts directly on pituitary somatotroph cells to stimulate the pulsatile release of growth hormone. Widely studied for its role in GH secretion dynamics and somatotropic axis research.
Research Use Only. Sermorelin Acetate is sold exclusively for in vitro research and laboratory use by qualified scientists. Not for human consumption, veterinary use, or clinical administration.
Research Literature
Published Research
Sermorelin stimulates pituitary GH secretion via GHRH receptor activation. Research focuses on GH axis restoration and somatotropic function.
Sermorelin: A better approach to management of adult-onset growth hormone insufficiency?
Key finding: Demonstrates restoration of GH pulsatility and IGF-1 levels in GH-deficient adults.
PubMed 10649284 ↗Effects of sermorelin on growth hormone secretion
Key finding: Dose-dependent GH release via direct pituitary somatotroph stimulation confirmed.
PubMed 8954023 ↗GHRH analogue comparison in clinical settings
Key finding: Sermorelin shows favorable half-life and GH release profile vs native GHRH.
PubMed 9349420 ↗Same Category